Gilles de la Tourette's syndrome

disorder

SNOMED 5158005CUI C0040517

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Mecamylamine hydrochloride

substance

Pergolide mesylate

substance

Ziprasidone hydrochloride

substance

Pergolide

substance

Clonidine

substance

Mecamylamine

substance

Haloperidol

substance

Risperidone

substance

Pimozide

substance

Clonidine hydrochloride

substance

Perphenazine

substance

Ziprasidone

substance

Ziprasidone mesylate

substance

Haloperidol decanoate

substance

Haloperidol lactate

substance

Ziprasidone hydrochloride monohydrate

substance

Ziprasidone hydrochloride anhydrous

substance

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Aggression

HP:0000718

Childhood attention deficit/hyperactivity disorder

HP:0007018

Echologia

HP:0010529

Motor tics

HP:0100034

OCD

HP:0000722

Phonic tics

HP:0100035

Self-mutilation

HP:0000742

Trouble sleeping

HP:0002360

Related Conditions

Dysphonia of Gilles de la Tourette's syndrome(child)

Extrapyramidal disease(parent)

Tic disorder(parent)

Quick Facts

SNOMED CT: 5158005
UMLS CUI: C0040517
Fully Specified Name: Gilles de la Tourette's syndrome (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 8
Known Treatments: 17

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.